Fondazione Per L'Istituto di Ricerca In Biomedicina

Fondazione Per L'Istituto di Ricerca In Biomedicina is a research organisation in Bellinzona, Switzerland that has taken part in 27 EU-funded projects since 2008, receiving €22.9M in EU funding and leading 11 as coordinator.

EU funding received€22.9M
EU projects27
As coordinator11
Running now5
First EU project2008
Latest project2027
CountrySwitzerland
EU registration (PIC)999460550
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fondazione Per L'Istituto di Ricerca In Biomedicina's own share of each project, not the project's full budget.

  • Horizon 2020€11.5M · 9 projects
  • FP7 (2007 to 2013)€8.0M · 13 projects
  • Horizon Europe€3.3M · 5 projects

Projects

27 EU-funded projects, newest first. Fondazione Per L'Istituto di Ricerca In Biomedicina led 11 of them as coordinator. Each links to the official record.

  • MISMATCHCoordinator

    Pathological and physiological roles of the MutL-gamma (MLH1-MLH3) nuclease: from harmful trinucleotide repeat expansions to promoting diversity in meiosis

    Horizon Europe · 2027–2032 · Project on CORDIS ↗

    €3.3Mtheir share
  • T-RAFICAssociated partner

    Training network for tracking and controlling therapeutic immune cells in cancer

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • IMMERGEAssociated partner

    Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • TOP-GUTAssociated partner

    Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • BRCA INSIGHTSCoordinator

    Understanding the functions of the BRCA protein complexes in DNA break repair and in replication stress

    Horizon 2020 · 2022–2027 · Project on CORDIS ↗

    €1.9Mtheir share
  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €43ktheir share
  • ATACPartner

    Antibody therapy against coronavirus (COVID-19)

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €3.9Mtheir share
  • TIL-FITCoordinator

    Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €1.4Mtheir share
  • TANTUMorNEUVACCINECoordinator

    Neutrophil subtypes: distinct cellular targets for therapeutic intervention

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €266ktheir share
  • RTCurePartner

    Rheuma Tolerance for Cure

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €183ktheir share
  • HRMECHCoordinator

    Nucleases in homologous recombination: from basic principles to genome editing

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €2.0Mtheir share
  • ZIKAlliancePartner

    A global alliance for Zika virus control and prevention

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

  • BROADimmuneCoordinator

    Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €1.9Mtheir share
  • IRINVACCoordinator

    IMMUNE RESPONSES TO INFLUENZA VACCINE

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €100ktheir share
  • PREDICTCoordinator

    Dissecting the human T cell response to pathogens, allergens, and self-antigens

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €2.5Mtheir share
  • LINFOEPABCoordinator

    CD4 T AND B LYMPHOCYTES IN HEPATITIS B PATIENTS: ROLE IN ACUTE AND CHRONIC INFECTION

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €248ktheir share
  • ABIRISKPartner

    Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €730ktheir share
  • TIMERPartner

    TargetIng novel MEchanisms of Resolution in inflammation

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €364ktheir share
  • ADITECPartner

    Advanced Immunization Technologies

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €521ktheir share
  • IDAMSPartner

    International Research Consortium on Dengue Risk Assessment, Management, and Surveillance

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €290ktheir share
  • RADARPartner

    Rationally Designed Aquatic Receptors integrated in label-free biosensor platforms for remote surveillance of toxins and pollutants

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €284ktheir share
  • IMMUNEXPLORECoordinator

    New approaches to analyze and exploit the human B and T cell response against viruses

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €2.0Mtheir share
  • NEWTBVACPartner

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €142ktheir share
  • MD-THIVCoordinator

    Migration and Differentiation of Th17 Cells in HIV/SIV Infection

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €181ktheir share
  • PEMPHIGUSPartner

    Pemphigus - From autoimmunity to disease

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €308ktheir share
  • IMECSPartner

    Identification of Mechanisms Correlating with Susceptibility for Avian Influenza

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €388ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • amines
  • antivirals
  • autoimmune diseases
  • bacteriology
  • biosensors
  • breast cancer
  • cell biology
  • cell signaling
  • cells technologies
  • chromosomes
  • coronaviruses
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime